| Product NDC: | 13668-141 | 
| Proprietary Name: | Clopidogrel Bisulfate | 
| Non Proprietary Name: | Clopidogrel Bisulfate | 
| Active Ingredient(s): | 75 mg/1 & nbsp; Clopidogrel Bisulfate | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 13668-141 | 
| Labeler Name: | Torrent Pharmaceuticals Limited | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA090844 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20120517 | 
| Package NDC: | 13668-141-44 | 
| Package Description: | 3100 TABLET in 1 BOTTLE (13668-141-44) | 
| NDC Code | 13668-141-44 | 
| Proprietary Name | Clopidogrel Bisulfate | 
| Package Description | 3100 TABLET in 1 BOTTLE (13668-141-44) | 
| Product NDC | 13668-141 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Clopidogrel Bisulfate | 
| Dosage Form Name | TABLET | 
| Route Name | ORAL | 
| Start Marketing Date | 20120517 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Torrent Pharmaceuticals Limited | 
| Substance Name | CLOPIDOGREL BISULFATE | 
| Strength Number | 75 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |